Kurma Partners, an Eurazeo group company, closes €215 million Biofund IV

by Eurazeo

Kurma Partners, a leading European healthcare venture capital firm, announces the final closing of Biofund IV at €215 million. This new fund continues to support Kurma’s strategy dedicated to the ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra advises Precinmac on its acquisi...

by Alantra

This transaction reinforces Alantra’s continued momentum in Aerospac...

Photos Stream